 |  |
Azurity Pharmaceuticals Announces Acquisition of Covis Pharma
By combining expertise and resources, Azurity strengthens its ability to deliver medicines to overlooked patients on a global scale.
Azurity Pharmaceuticals | 15/03/2025 | By Aishwarya
Azurity Pharmaceuticals Receives FDA Approval for Myhibbin
Mycophenolate mofetil, an antimetabolite immunosuppressant crucial in safeguarding transplanted organs from rejection by the body's immune system, is a vital medication for organ transplant recipients.
Azurity Pharmaceuticals | 07/05/2024 | By Abha | 143
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy